AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 21508941
Drug: usual pharmaceutical
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: usual pharmaceutical care (control)
Trial: 10442545
Drug: Topical corticosteroids
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical corticosteroids (beclomethasone dipropionate nasal spray, betamethasone nasal drops)
Trial: 10442545
Drug: Topical corticosteroids
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical corticosteroids (long-term therapy)
Trial: 8085929
Drug: Electrical stimulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electrical stimulation during continuous passive motion (CPM) treatment
Trial: 2670693
Drug: Recombinant interferon
RxNorm normalized name: Recombinant Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant interferon alpha 2A (Roferon‐A) at a dosage of 10 million units (MU)/m2 thrice weekly for six months
Trial: 2670693
Drug: Lower doses
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower doses of interferon (5 MU/m2 and 2.5 MU/m2)
Trial: 1066825
Drug: Supervised daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supervised daily dental and oral care
Trial: 11193131
Drug: CEE 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CEE 1.25 mg
Trial: 9590932
Drug: Occlusal splint
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occlusal splint therapy with a positioning orifice
Trial: 8290457
Drug: Povidone-iodine solution
RxNorm normalized name: POVIDONE-IODINE 1 g in 100 mL TOPICAL LIQUID [Loris Povidone-Iodine Solution]
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Povidone-iodine solution undiluted
Trial: 8290457
Drug: Povidone-iodine solution
RxNorm normalized name: POVIDONE-IODINE 1 g in 100 mL TOPICAL LIQUID [Loris Povidone-Iodine Solution]
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Povidone-iodine solution 1:10
Trial: 30043979
Drug: Lozenges containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lozenges containing specific IgY against P. gingivalis gingipains
Trial: 30043979
Drug: Placebo lozenges
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo lozenges (sham-immune IgY)
Trial: 27311914
Drug: EEG-guidance of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EEG-guidance of anaesthetic agent administration
Trial: 24516192
Drug: Upstream clopidogrel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Upstream clopidogrel treatment prior to catheterisation laboratory arrival
Trial: 24516192
Drug: No upstream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No upstream clopidogrel treatment
Trial: 23210197
Drug: Metronidazole (MTZ)
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metronidazole (MTZ) gel
Trial: 23210197
Drug: Chlorhexidine-Metronidazole (CHX-MTZ)
RxNorm normalized name: chlorhexidine / metronidazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorhexidine-Metronidazole (CHX-MTZ) gel
Trial: 19099126
Drug: Prednisone 2
RxNorm normalized name: prednisone 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone 2 mg/kg/day
Trial: 19099126
Drug: Prednisone tapering
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisone tapering to 0.5 mg/kg/day or less in one month
Trial: 16026380
Drug: Metformin +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin + sulphonylurea
Trial: 12032792
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (nonexposed and drug-exposed)
Trial: 12032792
Drug: Experimental group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental group (nonexposed and drug-exposed)
Trial: 12032792
Drug: Experimental group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental group (drug-exposed)
Trial: 12032792
Drug: Combined drug-specific
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined drug-specific groups (control+experimental)
Trial: 8914038
Drug: i.v. iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. iron dextran 5 ml every 2 weeks
Trial: 8914038
Drug: oral ferrous
RxNorm normalized name: ferrous fumarate Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: oral ferrous sulphate 200 mg tds
Trial: 1878232
Drug: Intramuscular piritramide
RxNorm normalized name: piritramide
DrugBank: Piritramide (DB12492)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular piritramide (7.5 to 15 mg as needed)
Trial: 1878232
Drug: Intravenous PCA
RxNorm normalized name: lauryl PCA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous PCA with fentanyl (demand dose 34 micrograms)
Trial: 1878232
Drug: Intravenous PCA
RxNorm normalized name: lauryl PCA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous PCA with buprenorphine (demand dose 80 micrograms)
Trial: 6751238
Drug: Oral theophylline
RxNorm normalized name: theophylline Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral theophylline and salbutamol combination
Trial: 6751238
Drug: Oral theophylline
RxNorm normalized name: theophylline Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral theophylline alone
Trial: 31519683
Drug: Operative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Operative treatment (surgery with suture anchors)
Trial: 21138358
Drug: Ketorolac adhesive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac adhesive film (30 mg) applied over the surgical site immediately after surgery.
Trial: 17847764
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist (GnRHa) continuously administered for 12 days after embryo transfer
Trial: 17847764
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist (GnRHa) stopped on the day of human chorionic gonadotropin administration
Trial: 2962878
Drug: Dopaminergic agonist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopaminergic agonist co-dergocrine
Trial: 2962878
Drug: Selective D-2
RxNorm normalized name: Vitamin D-2
DrugBank: Ergocalciferol (DB00153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Selective D-2 dopamine receptor blocker sulpiride
Trial: 31117218
Drug: 10 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g lactitol
Trial: 31117218
Drug: 3.5 g
RxNorm normalized name: Calcium 760 MG/3.5 GM Oral Granule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.5 g psyllium
Trial: 31117218
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 10 g lactitol and 3.5 g psyllium
Trial: 23137493
Drug: HeartNet (Paracor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HeartNet (Paracor Medical) plus optimal heart failure drug and device therapy
Trial: 23137493
Drug: Optimal drug
RxNorm normalized name: Optima Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optimal drug and device therapy alone
Trial: 6305244
Drug: Acyclovir, 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acyclovir, 5 mg/kg body weight at 8‐hour intervals for 5 days
Trial: 30223563
Drug: LFD and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LFD and TP arm (80 g of TP/day) for seven days
Trial: 12873959
Drug: Isobaric bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isobaric bupivacaine (3.5 mL, 17.5 mg mixed with 1.5 mL normal saline)
Trial: 12873959
Drug: Hypobaric bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypobaric bupivacaine (3.5 mL, 17.5 mg mixed with 1.5 mL distilled water)
Trial: 1882661
Drug: 1-mg gemeprost
RxNorm normalized name: gemeprost
DrugBank: Gemeprost (DB08964)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-mg gemeprost (Cervagem) pessary
Trial: 6341159
Drug: Golytely (an
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Golytely (an electrolyte‐polyethylene glycol solution)
Trial: 6341159
Drug: Standard 2-
RxNorm normalized name: epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard 2- and 3-day bowel preparations
Trial: 20626604
Drug: Mirodenafil 100
RxNorm normalized name: Mirodenafil
DrugBank: Mirodenafil (DB11792)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mirodenafil 100 mg on demand for 12 weeks
Trial: 18852533
Drug: Testosterone undecanoate
RxNorm normalized name: Testosterone Undecanoate
DrugBank: Testosterone undecanoate (DB13946)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone undecanoate (TU) 1000 mg every 6 to 9 weeks for 30 weeks, then 1000 mg every 12 weeks for 114 weeks
Trial: 18852533
Drug: Testosterone enanthate
RxNorm normalized name: Testosterone Enanthate
DrugBank: Testosterone enanthate (DB13944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone enanthate (TE) 250 mg every 3 weeks for 30 weeks
Trial: 18852533
Drug: Testosterone undecanoate
RxNorm normalized name: Testosterone Undecanoate
DrugBank: Testosterone undecanoate (DB13946)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone undecanoate (TU) 1000 mg every 12 weeks
Trial: 17512157
Drug: Sweat patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sweat patch testing
Trial: 1378143
Drug: Intravenous carvedilol
RxNorm normalized name: Carvedilol
DrugBank: Carvedilol (DB01136)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous carvedilol (12.5 mg in 1 h)
Trial: 1378143
Drug: Oral carvedilol
RxNorm normalized name: Carvedilol
DrugBank: Carvedilol (DB01136)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral carvedilol (25 mg)
Trial: 27100788
Drug: Statin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin (10 mg daily)
Trial: 25543420
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy (cutting method and western medication)
Trial: 12364430
Drug: Teriparatide (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Teriparatide (40 micro g)
Trial: 9846026
Drug: Dextromethorphan (DM)
RxNorm normalized name: Dextromethorphan
DrugBank: Dextromethorphan (DB00514)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dextromethorphan (DM) 30 mg three times a day
Trial: 8077527
Drug: Alteplase or
RxNorm normalized name: Alteplase
DrugBank: Alteplase (DB00009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alteplase or streptokinase therapy (group A)
Trial: 8077527
Drug: No reperfusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No reperfusion therapy (group B)
Trial: 1126582
Drug: Aerosol-spray M
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aerosol-spray M protein vaccine
Trial: 27137146
Drug: ALO-02 capsule
RxNorm normalized name: Aloe
DrugBank: Aloe ferox leaf (DB14257)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALO-02 capsule administered whole under fed conditions (high-fat breakfast ∼ 950 calories)
Trial: 27137146
Drug: ALO-02 capsule
RxNorm normalized name: Aloe
DrugBank: Aloe ferox leaf (DB14257)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALO-02 capsule administered whole under fasting conditions
Trial: 27137146
Drug: Single 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single 40 mg doses of ALO-02
Trial: 24004645
Drug: B-vitamins (folic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: B-vitamins (folic acid 2 mg, vitamin B6 25 mg, vitamin B12 500 μg)
Trial: 15527610
Drug: Drug treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug treatment knowledge for PTSD
Trial: 15527610
Drug: Recognition and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recognition and prescription knowledge for PTSD
Trial: 11207629
Drug: Low-dose oral
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose oral conjugated oestrogen (0.625 mg, CE)
Trial: 9870553
Drug: D-alpha-tocopherol 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-alpha-tocopherol 2 g/day
Trial: 9870553
Drug: L-ascorbic acid
RxNorm normalized name: L-ascorbic acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: L-ascorbic acid 3 g/day
Trial: 9870553
Drug: D-alpha-tocopherol 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-alpha-tocopherol 2 g/day combined with L-ascorbic acid 3 g/day
Trial: 8304606
Drug: Indomethacin 100-mg
RxNorm normalized name: indomethacin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin 100-mg rectal suppository
Trial: 8304606
Drug: Morphine by
RxNorm normalized name: By Ache
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine by IV titration (5-mg loading dose and up to two additional 2.5-mg doses if needed)
Trial: 30794165
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of parietal channels
Trial: 30794165
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of central and parietal channels
Trial: 22777834
Drug: Cediranib (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cediranib (3 mg/kg per dose daily)
Trial: 21482957
Drug: Vandetanib treatment
RxNorm normalized name: Vandetanib
DrugBank: Vandetanib (DB05294)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vandetanib treatment for 6 weeks
Trial: 21482957
Drug: Vandetanib treatment
RxNorm normalized name: Vandetanib
DrugBank: Vandetanib (DB05294)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vandetanib treatment
Trial: 18608400
Drug: Twice-weekly water
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice-weekly water exercise
Trial: 18608400
Drug: Once-weekly water
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-weekly water exercise
Trial: 18608400
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (once and twice weekly)
Trial: 14581144
Drug: Insulin Lispro
RxNorm normalized name: Insulin Lispro
DrugBank: Insulin lispro (DB00046)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin Lispro plus lunch and bedtime NPH insulin
Trial: 14581144
Drug: Premeal regular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Premeal regular insulin plus bedtime NPH insulin
Trial: 9666870
Drug: High-dose carbimazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose carbimazole (100 mg per day plus thyroxine)
Trial: 9666870
Drug: Low-dose carbimazole
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose carbimazole (starting at 25 mg, titrated)
Trial: 9666870
Drug: High-dose carbimazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose carbimazole
Trial: 9666870
Drug: Low-dose carbimazole
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose carbimazole
Trial: 13969
Drug: Bromazepam (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromazepam (mean daily dose: 23.8 mg)
Trial: 13969
Drug: Amitriptyline (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline (mean daily dose: 94 mg)
Trial: 2236455
Drug: Placebo (4.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (4.6 capsules)
Trial: 25782367
Drug: Self-reports of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-reports of medication side effects
Trial: 22085126
Drug: Immediate insertion
RxNorm normalized name: IR-3535
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate insertion of topical lignocaine gel
Trial: 22085126
Drug: 3‐min delay
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3‐min delay after lubrication with topical lignocaine gel
Trial: 15542277
Drug: MO.MA system
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MO.MA system (Invatec s.r.l.)
Trial: 11789280
Drug: Integrated laparoscopy
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Integrated laparoscopy with Chinese herbal medicine (combination group)
Trial: 11789280
Drug: Chinese herbal
RxNorm normalized name: GINGER 28 mg in 100 mL TOPICAL OIL [Pain Relief Honzo Seika Chinese Herbal Aroma Oil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese herbal medicine (TCM group)
Trial: 9279969
Drug: Lisinopril 10-20
RxNorm normalized name: lisinopril 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril 10-20 mg day-1
Trial: 8342402
Drug: Metoclopramide 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide 0.1 mg/kg
Trial: 8342402
Drug: Droperidol 10
RxNorm normalized name: droperidol 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droperidol 10 micrograms/kg and Metoclopramide 0.1 mg/kg
Trial: 26888338
Drug: Cefoperazone-sulbactam (CS)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefoperazone-sulbactam (CS) 2 g/8 h/day, IV
Trial: 26888338
Drug: Piperacillin-tazobactam (PIP-TAZO)
RxNorm normalized name: piperacillin / tazobactam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piperacillin-tazobactam (PIP-TAZO) 4.5 g/6 h/day, IV
Trial: 24636461
Drug: DDAVP nasal
RxNorm normalized name: DDAVP Nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DDAVP nasal spray (20mcg/day)
Trial: 12185379
Drug: Acarbose (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acarbose (100 to 300 mg/day)
Trial: 1860557
Drug: Insulin infusion
RxNorm normalized name: iLet Insulin Infusion 10-Pack Kit Inset
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin infusion rate of 120 mU.m‐2.min‐1
Trial: 1860557
Drug: Insulin infusion
RxNorm normalized name: iLet Insulin Infusion 10-Pack Kit Inset
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin infusion rate of 40 mU.m‐2.m‐1
Trial: 1860557
Drug: Higher insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Higher insulin infusion rate
Trial: 6336864
Drug: 1 gm
RxNorm normalized name: Ifex 1 GM Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 gm intravenous metronidazole preoperatively and five intravenous doses of 500 mg metronidazole postoperatively
Trial: 26649448
Drug: High-dose VM202
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose VM202 (n=20)
Trial: 26649448
Drug: Low-dose VM202
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose VM202 (n=21)
Trial: 24443876
Drug: Dapagliflozin 10
RxNorm normalized name: dapagliflozin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapagliflozin 10 mg + MET
Trial: 24443876
Drug: Ongoing weight
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ongoing weight loss (regardless of treatment arm)
Trial: 19008868
Drug: Catechin-rich beverage
RxNorm normalized name: catechin
DrugBank: Cianidanol (DB14086)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Catechin-rich beverage (582.8 mg of catechins per day)
Trial: 19008868
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (96.3 mg of catechins per day)
Trial: 15206989
Drug: CIC 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CIC 400 microg once daily
Trial: 15206989
Drug: FP 250
RxNorm normalized name: Coagulation Factor IX (Recombinant), Albumin Fusion Protein (rIX-FP)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FP 250 microg twice daily
Trial: 11207639
Drug: Dexamethasone (long
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (long course: 42-day tapering course)
Trial: 11207639
Drug: Dexamethasone (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (both treatment regimens)
Trial: 3182309
Drug: Melphalan (L-PAM)
RxNorm normalized name: Melphalan
DrugBank: Melphalan (DB01042)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Melphalan (L-PAM) and prednisone (pred) therapy for 12 weeks followed by total bone marrow irradiation (TBMI) at a dose of 1500 cGy
Trial: 3182309
Drug: Total bone
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total bone marrow irradiation (TBMI) at a dose of 1500 cGy
Trial: 31038755
Drug: FMT capsules
RxNorm normalized name: [18F]FMT
DrugBank: 6-[18F]-Fluoro-L-m-tyrosine (DB17621)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FMT capsules
Trial: 27269279
Drug: Bevacizumab (1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bevacizumab (1.25 mg/0.05 ml)
Trial: 23354008
Drug: AGEs inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AGEs inhibitor (benfotiamine [50 mg]+pyridoxamine [50 mg]+methylcobalamin [500 µg])
Trial: 9629989
Drug: Caffeine (CAF)
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine (CAF) - single oral dose (7 mg x kg(‐1))
Trial: 9629989
Drug: Creatine (CRE)
DrugBank: Creatine (DB00148)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Creatine (CRE) - repeated oral doses (3 x 100 mg x kg(‐1) x day(‐1)) for 3 days